ACADIA Pharmaceuticals, Inc. (ACAD)
29.11
-0.62
(-2.09%)
USD |
NASDAQ |
Aug 28, 16:00
29.12
+0.01
(+0.03%)
After-Hours: 20:00
ACADIA Pharmaceuticals Research and Development Expense (Annual) : 328.80M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 328.80M |
| December 31, 2024 | 303.25M |
| December 31, 2023 | 351.62M |
| December 31, 2022 | 361.58M |
| December 31, 2021 | 239.42M |
| December 31, 2020 | 266.33M |
| December 31, 2019 | 240.38M |
| December 31, 2018 | 187.16M |
| December 31, 2017 | 149.19M |
| December 31, 2016 | 99.28M |
| December 31, 2015 | 73.87M |
| December 31, 2014 | 60.60M |
| December 31, 2013 | 26.72M |
| Date | Value |
|---|---|
| December 31, 2012 | 18.79M |
| December 31, 2011 | 17.31M |
| December 31, 2010 | 19.98M |
| December 31, 2009 | 40.68M |
| December 31, 2008 | 55.05M |
| December 31, 2007 | 57.94M |
| December 31, 2006 | 49.40M |
| December 31, 2005 | 30.85M |
| December 31, 2004 | 23.45M |
| December 31, 2003 | 16.94M |
| December 31, 2002 | 14.92M |
| December 31, 2001 | 13.09M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Incyte Corp. | 1.984B |
| Agios Pharmaceuticals, Inc. | 334.36M |
| Biogen, Inc. | 1.481B |
| Insmed, Inc. | 771.09M |
| Vertex Pharmaceuticals, Inc. | 3.754B |